Clinical Trials
3 trialsNCT06344715 2024-04-03
Phase 1 Study Evaluating Safety and Tolerability of SL-T10, GX-I7, and Pembrolizumab Triple Combination in mCRPC.
SL VAXiGEN
Phase 1 Unknown
NCT05191784 2023-06-12
GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) Patients
Genexine, Inc.
Phase 2 Unknown
NCT03206138 2017-07-02
Safety and Efficacy of GX-188E Administered Via EP Plus GX-I7 or Imiquimod.
Seoul St. Mary's Hospital
Phase NA Unknown